rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
1
|
pubmed:dateCreated |
2002-10-16
|
pubmed:abstractText |
This study was undertaken to describe treatment outcomes in patients started on a re-treatment drug regimen, assess the quality of follow up procedures and the adequacy of the currently advocated re-treatment drug regimen in Nairobi, Kenya.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jan
|
pubmed:issn |
0012-835X
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
79
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
11-5
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:12380864-AIDS-Related Opportunistic Infections,
pubmed-meshheading:12380864-Adolescent,
pubmed-meshheading:12380864-Adult,
pubmed-meshheading:12380864-Aged,
pubmed-meshheading:12380864-Aged, 80 and over,
pubmed-meshheading:12380864-Antitubercular Agents,
pubmed-meshheading:12380864-Drug Therapy, Combination,
pubmed-meshheading:12380864-Female,
pubmed-meshheading:12380864-HIV Seropositivity,
pubmed-meshheading:12380864-Humans,
pubmed-meshheading:12380864-Isoniazid,
pubmed-meshheading:12380864-Kenya,
pubmed-meshheading:12380864-Male,
pubmed-meshheading:12380864-Middle Aged,
pubmed-meshheading:12380864-Pyrazinamide,
pubmed-meshheading:12380864-Recurrence,
pubmed-meshheading:12380864-Retrospective Studies,
pubmed-meshheading:12380864-Rifampin,
pubmed-meshheading:12380864-Treatment Outcome,
pubmed-meshheading:12380864-Tuberculosis, Pulmonary
|
pubmed:year |
2002
|
pubmed:articleTitle |
Tuberculosis re-treatment outcomes within the public service in Nairobi, Kenya.
|
pubmed:affiliation |
Centre for Respiratory Diseases Research, Kenya Medical Research Institute, Nairobi.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|